Investments in Research and Development for Supplemental Drug Indications—Implications for Drug Price Negotiations.

Autor: Vokinger, Kerstin N., Perényi, Gellért, Wouters, Olivier J.
Zdroj: JAMA Health Forum; 9/1/2023, Vol. 4 Issue 8, pe232798-e232798, 1p
Databáze: Complementary Index